A Clinical Study of Tobradex AF

Alcon

Status and phase: Completed; Phase 3

Conditions: Cataract

Treatments: Drug: Tobradex AF

Study type: Interventional

Funder types: Industry

Identifiers

NCT00473070

C-06-37

Details and patient eligibility

About

The purpose of this study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.

Enrollment: 900 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients requiring cataract surgery

Exclusion criteria

• Age related

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind